-
1
-
-
37749004225
-
Protein Therapeutics: A Summary and Pharmacological Classification
-
B. Leader Q. J. Baca D. E. Golan Protein Therapeutics: A Summary and Pharmacological Classification Nat. Rev. Drug Discovery 2008 7 21 39
-
(2008)
Nat. Rev. Drug Discovery
, vol.7
, pp. 21-39
-
-
Leader, B.1
Baca, Q.J.2
Golan, D.E.3
-
3
-
-
84884815498
-
Intestinal Mucosa Permeability Following Oral Insulin Delivery Using Core Shell Corona Nanolipoparticles
-
X. Li S. Guo C. Zhu Q. Zhu Y. Gan J. Rantanen U. L. Rahbek L. Hovgaard M. Yang Intestinal Mucosa Permeability Following Oral Insulin Delivery Using Core Shell Corona Nanolipoparticles Biomaterials 2013 34 9678 9687
-
(2013)
Biomaterials
, vol.34
, pp. 9678-9687
-
-
Li, X.1
Guo, S.2
Zhu, C.3
Zhu, Q.4
Gan, Y.5
Rantanen, J.6
Rahbek, U.L.7
Hovgaard, L.8
Yang, M.9
-
4
-
-
84941892373
-
Improved Oral Absorption of Exenatide Using an Original Nanoencapsulation and Microencapsulation Approach
-
L. Soudry-Kochavi N. Naraykin T. Nassar S. Benita Improved Oral Absorption of Exenatide Using an Original Nanoencapsulation and Microencapsulation Approach J. Controlled Release 2015 217 202 210
-
(2015)
J. Controlled Release
, vol.217
, pp. 202-210
-
-
Soudry-Kochavi, L.1
Naraykin, N.2
Nassar, T.3
Benita, S.4
-
5
-
-
84953306043
-
Nanotechnology for Protein Delivery: Overview and Perspectives
-
M. Yu J. Wu J. Shi O. C. Farokhzad Nanotechnology for Protein Delivery: Overview and Perspectives J. Controlled Release 2015 10.1016/j.jconrel.2015.10.012
-
(2015)
J. Controlled Release
-
-
Yu, M.1
Wu, J.2
Shi, J.3
Farokhzad, O.C.4
-
6
-
-
33748752402
-
Is the Oral Route Possible for Peptide and Protein Drug Delivery?
-
M. Morishita N. A. Peppas Is the Oral Route Possible for Peptide and Protein Drug Delivery? Drug Discovery Today 2006 11 905 910
-
(2006)
Drug Discovery Today
, vol.11
, pp. 905-910
-
-
Morishita, M.1
Peppas, N.A.2
-
7
-
-
84925871696
-
Targeting Membrane Transporters and Receptors as a Mean to Optimize Orally Delivered Biotechnological Based Drugs through Nanoparticle Delivery Systems
-
C. Pereira F. Araujo P. L. Granja H. A. Santos B. Sarmento Targeting Membrane Transporters and Receptors as a Mean to Optimize Orally Delivered Biotechnological Based Drugs through Nanoparticle Delivery Systems Curr. Pharm. Biotechnol. 2014 15 650 658
-
(2014)
Curr. Pharm. Biotechnol.
, vol.15
, pp. 650-658
-
-
Pereira, C.1
Araujo, F.2
Granja, P.L.3
Santos, H.A.4
Sarmento, B.5
-
8
-
-
84940121374
-
Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
-
F. Araújo N. Shrestha M. A. Shahbazi D. Liu B. Herranz-Blanco E. M. Mäkilä J. J. Salonen J. T. Hirvonen P. L. Granja B. Sarmento et al., Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs ACS Nano 2015 9 8291 8302
-
(2015)
ACS Nano
, vol.9
, pp. 8291-8302
-
-
Araújo, F.1
Shrestha, N.2
Shahbazi, M.A.3
Liu, D.4
Herranz-Blanco, B.5
Mäkilä, E.M.6
Salonen, J.J.7
Hirvonen, J.T.8
Granja, P.L.9
Sarmento, B.10
-
9
-
-
84879421792
-
Oral Delivery of Glucagon-Like Peptide-1 and Analogs: Alternatives for Diabetes Control?
-
F. Araújo P. Fonte H. A. Santos B. Sarmento Oral Delivery of Glucagon-Like Peptide-1 and Analogs: Alternatives for Diabetes Control? J. Diabetes Sci. Technol. 2012 6 1486 1497
-
(2012)
J. Diabetes Sci. Technol.
, vol.6
, pp. 1486-1497
-
-
Araújo, F.1
Fonte, P.2
Santos, H.A.3
Sarmento, B.4
-
10
-
-
34248223285
-
Biology of Incretins: Glp-1 and Gip
-
L. L. Baggio D. J. Drucker Biology of Incretins: Glp-1 and Gip Gastroenterology 2007 132 2131 2157
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
11
-
-
84925868886
-
Antihyperglycemic Potential of Incretins Orally Delivered Via Nano and Microsystems and Subsequent Glucoregulatory Effects
-
F. Araújo N. Shrestha P. L. Granja J. Hirvonen H. A. Santos B. Sarmento Antihyperglycemic Potential of Incretins Orally Delivered Via Nano and Microsystems and Subsequent Glucoregulatory Effects Curr. Pharm. Biotechnol. 2014 15 609 619
-
(2014)
Curr. Pharm. Biotechnol.
, vol.15
, pp. 609-619
-
-
Araújo, F.1
Shrestha, N.2
Granja, P.L.3
Hirvonen, J.4
Santos, H.A.5
Sarmento, B.6
-
12
-
-
84905913947
-
Synthesis, Characterization, and in Vitro Studies of Plga-Peg Nanoparticles for Oral Insulin Delivery
-
S. Hosseininasab R. Pashaei-Asl A. A. Khandaghi H. T. Nasrabadi K. Nejati-Koshki A. Akbarzadeh S. W. Joo Y. Hanifehpour S. Davaran Synthesis, Characterization, and in Vitro Studies of Plga-Peg Nanoparticles for Oral Insulin Delivery Chem. Biol. Drug Des. 2014 84 307 315
-
(2014)
Chem. Biol. Drug Des.
, vol.84
, pp. 307-315
-
-
Hosseininasab, S.1
Pashaei-Asl, R.2
Khandaghi, A.A.3
Nasrabadi, H.T.4
Nejati-Koshki, K.5
Akbarzadeh, A.6
Joo, S.W.7
Hanifehpour, Y.8
Davaran, S.9
-
14
-
-
84996453951
-
Enhanced Oral Bioavailability of Insulin Using Plga Nanoparticles Co-Modified with Cell-Penetrating Peptides and Engrailed Secretion Peptide (Sec)
-
S. Zhu S. Chen Y. Gao F. Guo F. Li B. Xie J. Zhou H. Zhong Enhanced Oral Bioavailability of Insulin Using Plga Nanoparticles Co-Modified with Cell-Penetrating Peptides and Engrailed Secretion Peptide (Sec) Drug Delivery 2015 1 12
-
(2015)
Drug Delivery
, pp. 1-12
-
-
Zhu, S.1
Chen, S.2
Gao, Y.3
Guo, F.4
Li, F.5
Xie, B.6
Zhou, J.7
Zhong, H.8
-
16
-
-
84883828905
-
Population Pharmacodynamic Modeling of Exenatide after 2-Week Treatment in Stz/Na Diabetic Rats
-
T. Chen L. Kagan D. E. Mager Population Pharmacodynamic Modeling of Exenatide after 2-Week Treatment in Stz/Na Diabetic Rats J. Pharm. Sci. 2013 102 3844 3851
-
(2013)
J. Pharm. Sci.
, vol.102
, pp. 3844-3851
-
-
Chen, T.1
Kagan, L.2
Mager, D.E.3
-
17
-
-
84907207085
-
A Survey on Trojan Horse Peptides: Opportunities, Issues and Controlled Entry to Troy
-
N. Q. Shi X. R. Qi B. Xiang Y. Zhang A Survey on "Trojan Horse" Peptides: Opportunities, Issues and Controlled Entry to "Troy" J. Controlled Release 2014 194 53 70
-
(2014)
J. Controlled Release
, vol.194
, pp. 53-70
-
-
Shi, N.Q.1
Qi, X.R.2
Xiang, B.3
Zhang, Y.4
-
18
-
-
84878782419
-
Cell-Penetrating Peptides: 20 Years Later, Where Do We Stand?
-
C. Bechara S. Sagan Cell-Penetrating Peptides: 20 Years Later, Where Do We Stand? FEBS Lett. 2013 587 1693 1702
-
(2013)
FEBS Lett.
, vol.587
, pp. 1693-1702
-
-
Bechara, C.1
Sagan, S.2
-
19
-
-
84904188661
-
Fabrication of a Multifunctional Nano-in-Micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
-
H. Zhang D. Liu M. A. Shahbazi E. Mäkilä B. Herranz-Blanco J. Salonen J. Hirvonen H. A. Santos Fabrication of a Multifunctional Nano-in-Micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix Adv. Mater. 2014 26 4497 4503
-
(2014)
Adv. Mater.
, vol.26
, pp. 4497-4503
-
-
Zhang, H.1
Liu, D.2
Shahbazi, M.A.3
Mäkilä, E.4
Herranz-Blanco, B.5
Salonen, J.6
Hirvonen, J.7
Santos, H.A.8
-
20
-
-
84901284579
-
Microfluidic Assembly of Monodisperse Multistage Ph-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
-
D. Liu H. Zhang B. Herranz-Blanco E. Mäkilä V. P. Lehto J. Salonen J. Hirvonen H. A. Santos Microfluidic Assembly of Monodisperse Multistage Ph-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery Small 2014 10 2029 2038
-
(2014)
Small
, vol.10
, pp. 2029-2038
-
-
Liu, D.1
Zhang, H.2
Herranz-Blanco, B.3
Mäkilä, E.4
Lehto, V.P.5
Salonen, J.6
Hirvonen, J.7
Santos, H.A.8
-
21
-
-
84927135427
-
Self-Coated Interfacial Layer at Organic/Inorganic Phase for Temporally Controlling Dual-Drug Delivery from Electrospun Fibers
-
X. Zhao J. Zhao Z. Y. Lin G. Pan Y. Zhu Y. Cheng W. Cui Self-Coated Interfacial Layer at Organic/Inorganic Phase for Temporally Controlling Dual-Drug Delivery from Electrospun Fibers Colloids Surf., B 2015 130 1 9
-
(2015)
Colloids Surf., B
, vol.130
, pp. 1-9
-
-
Zhao, X.1
Zhao, J.2
Lin, Z.Y.3
Pan, G.4
Zhu, Y.5
Cheng, Y.6
Cui, W.7
-
22
-
-
84971305913
-
Integrated Therapy on Residual Tumor after Palliative Operation Using Dual-Phase Drug Releasing Electrospun Fibrous Scaffolds
-
Z. Yuan J. Zhao Z. Yang X. Wang Q. Zheng W. Cui Integrated Therapy on Residual Tumor after Palliative Operation Using Dual-Phase Drug Releasing Electrospun Fibrous Scaffolds J. Controlled Release 2015 213 e151 e152
-
(2015)
J. Controlled Release
, vol.213
, pp. e151-e152
-
-
Yuan, Z.1
Zhao, J.2
Yang, Z.3
Wang, X.4
Zheng, Q.5
Cui, W.6
-
23
-
-
0022396958
-
Toxicological Studies of Hydroxypropylmethylcellulose Acetate Succinate-Acute Toxicity in Rats and Rabbits, and Subchronic and Chronic Toxicities in Rats
-
N. Hoshi H. Yano K. Hirashima H. Kitagawa Y. Fukuda Toxicological Studies of Hydroxypropylmethylcellulose Acetate Succinate-Acute Toxicity in Rats and Rabbits, and Subchronic and Chronic Toxicities in Rats J. Toxicol. Sci. 1985 10 Suppl 2 147 185
-
(1985)
J. Toxicol. Sci.
, vol.10
, pp. 147-185
-
-
Hoshi, N.1
Yano, H.2
Hirashima, K.3
Kitagawa, H.4
Fukuda, Y.5
-
24
-
-
84939628067
-
Multistage Ph-Responsive Mucoadhesive Nanocarriers Prepared by Aerosol Flow Reactor Technology: A Controlled Dual Protein-Drug Delivery System
-
N. Shrestha M. A. Shahbazi F. Araújo E. Mäkilä J. Raula E. I. Kauppinen J. Salonen B. Sarmento J. Hirvonen H. A. Santos Multistage Ph-Responsive Mucoadhesive Nanocarriers Prepared by Aerosol Flow Reactor Technology: A Controlled Dual Protein-Drug Delivery System Biomaterials 2015 68 9 20
-
(2015)
Biomaterials
, vol.68
, pp. 9-20
-
-
Shrestha, N.1
Shahbazi, M.A.2
Araújo, F.3
Mäkilä, E.4
Raula, J.5
Kauppinen, E.I.6
Salonen, J.7
Sarmento, B.8
Hirvonen, J.9
Santos, H.A.10
-
25
-
-
84906788144
-
The Impact of Nanoparticles on the Mucosal Translocation and Transport of Glp-1 across the Intestinal Epithelium
-
F. Araújo N. Shrestha M. A. Shahbazi P. Fonte E. M. Mäkilä J. J. Salonen J. T. Hirvonen P. L. Granja H. A. Santos B. Sarmento The Impact of Nanoparticles on the Mucosal Translocation and Transport of Glp-1 across the Intestinal Epithelium Biomaterials 2014 35 9199 9207
-
(2014)
Biomaterials
, vol.35
, pp. 9199-9207
-
-
Araújo, F.1
Shrestha, N.2
Shahbazi, M.A.3
Fonte, P.4
Mäkilä, E.M.5
Salonen, J.J.6
Hirvonen, J.T.7
Granja, P.L.8
Santos, H.A.9
Sarmento, B.10
-
26
-
-
84884134395
-
Effect of Surface Chemistry of Porous Silicon Microparticles on Glucagon-Like Peptide-1 (Glp-1) Loading, Release and Biological Activity
-
A. Huotari W. Xu J. Monkare M. Kovalainen K. H. Herzig V. P. Lehto K. Jarvinen Effect of Surface Chemistry of Porous Silicon Microparticles on Glucagon-Like Peptide-1 (Glp-1) Loading, Release and Biological Activity Int. J. Pharm. 2013 454 67 73
-
(2013)
Int. J. Pharm.
, vol.454
, pp. 67-73
-
-
Huotari, A.1
Xu, W.2
Monkare, J.3
Kovalainen, M.4
Herzig, K.H.5
Lehto, V.P.6
Jarvinen, K.7
-
27
-
-
0031939587
-
Experimental Niddm: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide
-
P. Masiello C. Broca R. Gross M. Roye M. Manteghetti D. Hillaire-Buys M. Novelli G. Ribes Experimental Niddm: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide Diabetes 1998 47 224 229
-
(1998)
Diabetes
, vol.47
, pp. 224-229
-
-
Masiello, P.1
Broca, C.2
Gross, R.3
Roye, M.4
Manteghetti, M.5
Hillaire-Buys, D.6
Novelli, M.7
Ribes, G.8
-
28
-
-
58549086777
-
New Orally Available Glucagon-Like Peptide-1 Receptor Agonist, Biotinylated Exendin-4, Displays Improved Hypoglycemic Effects in Db/Db Mice
-
C.-H. Jin S. Y. Chae S. Son T. H. Kim K. A. Um Y. S. Youn S. Lee K. C. A. Lee New Orally Available Glucagon-Like Peptide-1 Receptor Agonist, Biotinylated Exendin-4, Displays Improved Hypoglycemic Effects in Db/Db Mice J. Controlled Release 2009 133 172 177
-
(2009)
J. Controlled Release
, vol.133
, pp. 172-177
-
-
Jin, C.-H.1
Chae, S.Y.2
Son, S.3
Kim, T.H.4
Um, K.A.5
Youn, Y.S.6
Lee, S.7
Lee, K.C.A.8
-
29
-
-
84902079022
-
Chitosan-Modified Porous Silicon Microparticles for Enhanced Permeability of Insulin across Intestinal Cell Monolayers
-
N. Shrestha M. A. Shahbazi F. Araújo H. Zhang E. M. Mäkilä J. Kauppila B. Sarmento J. J. Salonen J. T. Hirvonen H. A. Santos Chitosan-Modified Porous Silicon Microparticles for Enhanced Permeability of Insulin across Intestinal Cell Monolayers Biomaterials 2014 35 7172 7179
-
(2014)
Biomaterials
, vol.35
, pp. 7172-7179
-
-
Shrestha, N.1
Shahbazi, M.A.2
Araújo, F.3
Zhang, H.4
Mäkilä, E.M.5
Kauppila, J.6
Sarmento, B.7
Salonen, J.J.8
Hirvonen, J.T.9
Santos, H.A.10
-
30
-
-
84875913755
-
Oligoarginine-Modified Biodegradable Nanoparticles Improve the Intestinal Absorption of Insulin
-
X. Liu C. Liu W. Zhang C. Xie G. Wei W. Lu Oligoarginine-Modified Biodegradable Nanoparticles Improve the Intestinal Absorption of Insulin Int. J. Pharm. 2013 448 159 167
-
(2013)
Int. J. Pharm.
, vol.448
, pp. 159-167
-
-
Liu, X.1
Liu, C.2
Zhang, W.3
Xie, C.4
Wei, G.5
Lu, W.6
-
32
-
-
73949087550
-
Effect of Surface Properties on Nanoparticle-Cell Interactions
-
A. Verma F. Stellacci Effect of Surface Properties on Nanoparticle-Cell Interactions Small 2010 6 12 21
-
(2010)
Small
, vol.6
, pp. 12-21
-
-
Verma, A.1
Stellacci, F.2
-
33
-
-
84871923480
-
Cycloart-23-Ene-3beta, 25-Diol Stimulates Glp-1 (7-36) Amide Secretion in Streptozotocin-Nicotinamide Induced Diabetic Sprague Dawley Rats: A Mechanistic Approach
-
S. L. Badole S. P. Mahamuni P. P. Bagul R. D. Khose A. C. Joshi A. E. Ghule S. L. Bodhankar C. G. Raut V. M. Khedkar E. C. Coutinho et al., Cycloart-23-Ene-3beta, 25-Diol Stimulates Glp-1 (7-36) Amide Secretion in Streptozotocin-Nicotinamide Induced Diabetic Sprague Dawley Rats: A Mechanistic Approach Eur. J. Pharmacol. 2013 698 470 479
-
(2013)
Eur. J. Pharmacol.
, vol.698
, pp. 470-479
-
-
Badole, S.L.1
Mahamuni, S.P.2
Bagul, P.P.3
Khose, R.D.4
Joshi, A.C.5
Ghule, A.E.6
Bodhankar, S.L.7
Raut, C.G.8
Khedkar, V.M.9
Coutinho, E.C.10
-
34
-
-
84914164473
-
Streptozotocin-Nicotinamide-Induced Rat Model of Type 2 Diabetes (Review)
-
A. Ghasemi S. Khalifi S. Jedi Streptozotocin-Nicotinamide-Induced Rat Model of Type 2 Diabetes (Review) Acta Physiol. Hung. 2014 101 408 420
-
(2014)
Acta Physiol. Hung.
, vol.101
, pp. 408-420
-
-
Ghasemi, A.1
Khalifi, S.2
Jedi, S.3
-
35
-
-
33644833635
-
Animal Models of Type 2 Diabetes with Reduced Pancreatic B-Cell Mass
-
P. Masiello Animal Models of Type 2 Diabetes with Reduced Pancreatic B-Cell Mass Int. J. Biochem. Cell Biol. 2006 38 873 893
-
(2006)
Int. J. Biochem. Cell Biol.
, vol.38
, pp. 873-893
-
-
Masiello, P.1
-
36
-
-
54049155669
-
Resveratrol, a Natural Phytoalexin, Normalizes Hyperglycemia in Streptozotocin-Nicotinamide Induced Experimental Diabetic Rats
-
P. Palsamy S. Subramanian Resveratrol, a Natural Phytoalexin, Normalizes Hyperglycemia in Streptozotocin-Nicotinamide Induced Experimental Diabetic Rats Biomed. Pharmacother. 2008 62 598 605
-
(2008)
Biomed. Pharmacother.
, vol.62
, pp. 598-605
-
-
Palsamy, P.1
Subramanian, S.2
-
37
-
-
84918828617
-
Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats
-
Y. Nayak V. Hillemane V. K. Daroji B. S. Jayashree M. K. Unnikrishnan Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats Sci. World J. 2014 2014 854267
-
(2014)
Sci. World J.
, vol.2014
, pp. 854267
-
-
Nayak, Y.1
Hillemane, V.2
Daroji, V.K.3
Jayashree, B.S.4
Unnikrishnan, M.K.5
-
38
-
-
39849102053
-
Improved Peroral Delivery of Glucagon-Like Peptide-1 by Site-Specific Biotin Modification: Design, Preparation, and Biological Evaluation
-
Y. S. Youn S. Y. Chae S. Lee M. J. Kwon H. J. Shin K. C. Lee Improved Peroral Delivery of Glucagon-Like Peptide-1 by Site-Specific Biotin Modification: Design, Preparation, and Biological Evaluation Eur. J. Pharm. Biopharm. 2008 68 667 675
-
(2008)
Eur. J. Pharm. Biopharm.
, vol.68
, pp. 667-675
-
-
Youn, Y.S.1
Chae, S.Y.2
Lee, S.3
Kwon, M.J.4
Shin, H.J.5
Lee, K.C.6
-
39
-
-
79251593382
-
The Glucose-Lowering Potential of Exendin-4 Orally Delivered Via a Ph-Sensitive Nanoparticle Vehicle and Effects on Subsequent Insulin Secretion in Vivo
-
H. N. Nguyen S. P. Wey J. H. Juang K. Sonaje Y. C. Ho E. Y. Chuang C. W. Hsu T. C. Yen K. J. Lin H. W. Sung The Glucose-Lowering Potential of Exendin-4 Orally Delivered Via a Ph-Sensitive Nanoparticle Vehicle and Effects on Subsequent Insulin Secretion in Vivo Biomaterials 2011 32 2673 2682
-
(2011)
Biomaterials
, vol.32
, pp. 2673-2682
-
-
Nguyen, H.N.1
Wey, S.P.2
Juang, J.H.3
Sonaje, K.4
Ho, Y.C.5
Chuang, E.Y.6
Hsu, C.W.7
Yen, T.C.8
Lin, K.J.9
Sung, H.W.10
-
40
-
-
0035041250
-
Defective Glucose-Dependent Insulinotropic Polypeptide Receptor Expression in Diabetic Fatty Zucker Rats
-
F. C. Lynn N. Pamir E. H. Ng C. H. McIntosh T. J. Kieffer R. A. Pederson Defective Glucose-Dependent Insulinotropic Polypeptide Receptor Expression in Diabetic Fatty Zucker Rats Diabetes 2001 50 1004 1011
-
(2001)
Diabetes
, vol.50
, pp. 1004-1011
-
-
Lynn, F.C.1
Pamir, N.2
Ng, E.H.3
McIntosh, C.H.4
Kieffer, T.J.5
Pederson, R.A.6
-
41
-
-
79959778328
-
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Review of Their Efficacy and Tolerability
-
A. J. Garber Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Review of Their Efficacy and Tolerability Diabetes Care 2011 34 Suppl 2 S279 S284
-
(2011)
Diabetes Care
, vol.342
, pp. S279-S284
-
-
Garber, A.J.1
-
42
-
-
0036107064
-
Long-Term Inhibition of Dipeptidyl Peptidase IV Improves Glucose Tolerance and Preserves Islet Function in Mice
-
M. K. Reimer J. J. Holst B. Ahren Long-Term Inhibition of Dipeptidyl Peptidase Iv Improves Glucose Tolerance and Preserves Islet Function in Mice Eur. J. Endocrinol./Eur. Fed. Endocrine Soc. 2002 146 717 727
-
(2002)
Eur. J. Endocrinol./Eur. Fed. Endocrine Soc.
, vol.146
, pp. 717-727
-
-
Reimer, M.K.1
Holst, J.J.2
Ahren, B.3
-
43
-
-
84862771028
-
Early Intervention with Liraglutide Improves Glucose Tolerance without Affecting Islet Microcirculation in Young Goto-Kakizaki Rats
-
L. Wu A. Olverling L. Fransson H. Ortsäter C. Kappe X. Gao Å. Sjöholm Early Intervention with Liraglutide Improves Glucose Tolerance without Affecting Islet Microcirculation in Young Goto-Kakizaki Rats Regul. Pept. 2012 177 92 96
-
(2012)
Regul. Pept.
, vol.177
, pp. 92-96
-
-
Wu, L.1
Olverling, A.2
Fransson, L.3
Ortsäter, H.4
Kappe, C.5
Gao, X.6
Sjöholm, Å.7
-
44
-
-
83455230039
-
Dipeptidyl Peptidase-4 Inhibitors and Preservation of Pancreatic Islet-Cell Function: A Critical Appraisal of the Evidence
-
R. E. van Genugten D. H. van Raalte M. Diamant Dipeptidyl Peptidase-4 Inhibitors and Preservation of Pancreatic Islet-Cell Function: A Critical Appraisal of the Evidence Diabetes, Obes. Metab. 2012 14 101 111
-
(2012)
Diabetes, Obes. Metab.
, vol.14
, pp. 101-111
-
-
Van Genugten, R.E.1
Van Raalte, D.H.2
Diamant, M.3
-
45
-
-
58149144587
-
The Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Combination with Pioglitazone Improves Glycemic Control, Lipid Profiles, and Increases Pancreatic Insulin Content in Ob/Ob Mice
-
Y. Moritoh K. Takeuchi T. Asakawa O. Kataoka H. Odaka The Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Combination with Pioglitazone Improves Glycemic Control, Lipid Profiles, and Increases Pancreatic Insulin Content in Ob/Ob Mice Eur. J. Pharmacol. 2009 602 448 454
-
(2009)
Eur. J. Pharmacol.
, vol.602
, pp. 448-454
-
-
Moritoh, Y.1
Takeuchi, K.2
Asakawa, T.3
Kataoka, O.4
Odaka, H.5
-
46
-
-
46549087133
-
Chronic Administration of Alogliptin, a Novel, Potent, and Highly Selective Dipeptidyl Peptidase-4 Inhibitor, Improves Glycemic Control and Beta-Cell Function in Obese Diabetic Ob/Ob Mice
-
Y. Moritoh K. Takeuchi T. Asakawa O. Kataoka H. Odaka Chronic Administration of Alogliptin, a Novel, Potent, and Highly Selective Dipeptidyl Peptidase-4 Inhibitor, Improves Glycemic Control and Beta-Cell Function in Obese Diabetic Ob/Ob Mice Eur. J. Pharmacol. 2008 588 325 332
-
(2008)
Eur. J. Pharmacol.
, vol.588
, pp. 325-332
-
-
Moritoh, Y.1
Takeuchi, K.2
Asakawa, T.3
Kataoka, O.4
Odaka, H.5
-
47
-
-
23844458304
-
Function of a Long-Term, Glp-1-Treated, Insulin-Secreting Cell Line Is Improved by Preventing Dpp IV-Mediated Degradation of Glp-1
-
B. D. Green H. K. Liu J. T. McCluskey N. A. Duffy F. P. O'Harte N. H. McClenaghan P. R. Flatt Function of a Long-Term, Glp-1-Treated, Insulin-Secreting Cell Line Is Improved by Preventing Dpp Iv-Mediated Degradation of Glp-1 Diabetes, Obes. Metab. 2005 7 563 569
-
(2005)
Diabetes, Obes. Metab.
, vol.7
, pp. 563-569
-
-
Green, B.D.1
Liu, H.K.2
McCluskey, J.T.3
Duffy, N.A.4
O'Harte, F.P.5
McClenaghan, N.H.6
Flatt, P.R.7
-
48
-
-
77954611378
-
Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating Beta-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
-
L. Tian J. Gao J. Hao Y. Zhang H. Yi T. D. O'Brien R. Sorenson J. Luo Z. Guo Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating Beta-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase Iv Inhibitor Endocrinology 2010 151 3049 3060
-
(2010)
Endocrinology
, vol.151
, pp. 3049-3060
-
-
Tian, L.1
Gao, J.2
Hao, J.3
Zhang, Y.4
Yi, H.5
O'Brien, T.D.6
Sorenson, R.7
Luo, J.8
Guo, Z.9
-
49
-
-
0000135759
-
Inhibition of Dipeptidyl Peptidase IV with Nvp-Dpp728 Increases Plasma Glp-1 (7-36 Amide) Concentrations and Improves Oral Glucose Tolerance in Obese Zucker Rats
-
B. Balkan L. Kwasnik R. Miserendino J. J. Holst X. Li Inhibition of Dipeptidyl Peptidase Iv with Nvp-Dpp728 Increases Plasma Glp-1 (7-36 Amide) Concentrations and Improves Oral Glucose Tolerance in Obese Zucker Rats Diabetologia 1999 42 1324 1331
-
(1999)
Diabetologia
, vol.42
, pp. 1324-1331
-
-
Balkan, B.1
Kwasnik, L.2
Miserendino, R.3
Holst, J.J.4
Li, X.5
|